Status:
UNKNOWN
Chronic Recurrent Multifocal Osteomyelitis - a Bacterial Cause?
Lead Sponsor:
Rigshospitalet, Denmark
Collaborating Sponsors:
Region Sjælland
Conditions:
Chronic Recurrent Multifocal Osteomyelitis
Eligibility:
All Genders
Up to 18 years
Phase:
NA
Brief Summary
Chronic recurrent multifocal osteomyelitis (CRMO) is an immune-mediated chronic inflammatory self- limiting disease with non-suppurative inflammation involving one or multiple bone foci. A bacterial e...
Detailed Description
Epidemiology, clinical manifestations and prognosis Chronic recurrent multifocal osteomyelitis (CRMO) is an immune-mediated chronic inflammatory self- limiting disease with non-suppurative inflammatio...
Eligibility Criteria
Inclusion
- CRMO diagnosis verified by biopsy
- Age under 18 years at diagnosis
- Malignant disease excluded
- Informed written consent
Exclusion
- Bone biopsy not performed
- Patients not eligible for MRI (metallic foreign objects, severe claustrophobia)
- Pregnancy
Key Trial Info
Start Date :
November 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT03433287
Start Date
November 1 2015
End Date
December 1 2022
Last Update
May 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, Denmark, 2100